ProJenX

0 followers


ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways. The company was founded in 2021 and is headquartered in Nissequogue, New York.

Industries

+1

Headquarters

Stage

Employees

Links

Org chart

Stan Abel
President and Chief Executive Officer

Stan Abel

Collapse
Emily R. Lowry, Ph.D.
Scientific Co-Founder and Senior Scientific Advisor